ArticleJournal of pathology and translational medicine2025

The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers.

Ji-Ae Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.